Nurun Khandaker
Family Medicine · Bakersfield, CANPI 1578597332
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 290 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 290 payments — averaging $34.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Lilly USA, LLC$1K
- Novo Nordisk$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$834
- Amgen$625
- GSK$599
- plus $3K from 26 others
What the payments were for
- Food & beverage$9,994100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 38 | $2,264 |
| Lilly USA, LLC | 51 | $1,395 |
| Novo Nordisk | 34 | $1,087 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 58 | $834 |
| Amgen | 5 | $625 |
| GSK | 10 | $599 |
| AbbVie(2 entities) | 25 | $494 |
| Boehringer Ingelheim | 16 | $361 |
| Corcept Therapeutics | 4 | $291 |
| Otsuka America Pharmaceutical, Inc. | 2 | $247 |
| Merck | 12 | $210 |
| Pfizer | 8 | $163 |
| Medtronic(2 entities) | 2 | $152 |
| Nevro Corp. | 1 | $139 |
| Bayer | 2 | $135 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| Biosense Webster, Inc. | 1 | $122 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $113 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $96 |
| Intercept Pharmaceuticals, Inc. | 1 | $86 |
| Silk Road Medical, Inc. | 1 | $80 |
| Phathom Pharmaceuticals, Inc. | 2 | $79 |
| Angiodynamics, Inc. | 1 | $64 |
| Currax Pharmaceuticals LLC | 3 | $46 |
| Idorsia Pharmaceuticals US Inc | 2 | $44 |
| Coloplast | 2 | $41 |
| Vertex | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,007 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 14 | $29 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bakersfield
- Amira AyadBakersfield$360K
- Matthew BeareBakersfield$98K
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.